哈佛大學研究員大衛辛克萊博士正面臨長壽界的強烈反對。根據《華爾街日報》報道,批評者認為他對「逆轉衰老」的說法太過分了。長壽藥物正在吸引全球最富有的高管數十億美元的投資。 Harvard researcher Dr. David Sinclair is facing backlash in the longevity community. Critics argue that he took claims about "reverse aging" too far, The Wall Street Journal reported. Longevity medicine is attracting billions in investment from the world's wealthiest execs. Apr 28, 2024
@Youtuber_1016 ай бұрын
MIN 老師妳好 如果nmn/nr 服用的同時, 一同服用一些被認為能減低癌症發生的補充品, 是否能做到增加NAD plus 但又降低患癌風險的效果? 例如 Fucoidan, Quercetin....